Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The aim of this possible study is to identify if SARS-CoV-2 can be found in the tear film and conjunctiva of a patient with COVID-19.
Description: The primary endpoint is the number of conjunctival swabs tested positive for SARS-CoV2.
Measure: SARS-CoV2 positive conjunctival swabs Time: 1 yearDescription: The secondary target is the difference between the conjunctival swab tested positive for SARS-CoV2 and the nasopharyngeal swab.
Measure: Conjunctival swab vs nasopharyngeal swab Time: 1 yearDescription: In the case of a SARS-COV 2 positive conjunctival swab a virus culture will be conducted to clarify, whether it is a viable virus or virus RNA fragments.
Measure: Viability of SARS-COV 2 Time: 1 year